RBC Capital analyst Ben Hendrix reiterated a Buy rating on AdaptHealth (AHCO – Research Report) yesterday and set a price target of $13.00. The company’s shares closed last Friday at $10.52.
Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, Humana, and CVS Health. According to TipRanks, Hendrix has an average return of 3.2% and a 56.68% success rate on recommended stocks.
In addition to RBC Capital, AdaptHealth also received a Buy from Truist Financial’s David S Macdonald in a report issued on February 28. However, on February 27, Stifel Nicolaus maintained a Hold rating on AdaptHealth (NASDAQ: AHCO).
See Insiders’ Hot Stocks on TipRanks >>
Based on AdaptHealth’s latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $254.5 million. In comparison, last year the company had a GAAP net loss of $2.59 million
Based on the recent corporate insider activity of 41 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AHCO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AdaptHealth (AHCO) Company Description:
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Read More on AHCO:
